ebook Munafa Stock Market Course + Intraday & FNO calls  

       

CHRS announcements Coherus Biosciences, Inc. announcements and dividends declared USA

Coherus Biosciences, Inc. Complete list of announcements declared & dividend announcements by Coherus Biosciences, Inc. CHRS

Coherus Biosciences, Inc. CHRS listed on USA and deals in Health Care Biotechnology Biological Products No Diagnostic Substances

Announcements and dividends declared by Coherus Biosciences, Inc. CHRS

Coherus BioSciences Announces Data From Ongoing Phase 1 Clinical Trial Evaluating CHS-114
(RTTNews) - Coherus BioSciences, Inc. (CHRS), Monday announced data from its ongoing Phase 1 clinical trial evaluating CHS-114, a selective, cytolytic anti-CCR8 antibody, as monotherapy and in combination with toripalimab in patients with recurrent/metasta
Announcement as on 28 April 2025

Coherus BioSciences To Buy Back 0 Mln Of 1.500% Convertible Sr. Subordinated Notes
(RTTNews) - Coherus BioSciences, Inc. (CHRS) Tuesday said it has agreed to buy back about 0 million of its 1.500% convertible senior subordinated notes due 2026 at its principal plus interest amount.
Announcement as on 01 April 2025

Why Coherus Biosciences Stock Tumbled on Thursday
The final set of results for Coherus Biosciences' (NASDAQ: CHRS) 2023 was released after market hours on Wednesday, and investors reacted with displeasure the following day. They traded the stock down by more than 6% Thursday, a much steeper fall than the
Announcement as on 14 March 2024

: Coherus BioSciences’ new injector treatment for cancer patients rejected by FDA
Coherus BioSciences said Monday that the U.S. Food and Drug Administration rejected its regulatory submission for a new on-body injector form of Udenyca, a treatment designed to cut cancer patients’ risk of infection after chemotherapy. The rejection was
Announcement as on 25 September 2023

Announcements by Coherus Biosciences, Inc. first page |

CHRS Coherus Biosciences, Inc. current price & indicator signals

Moving Averages for Coherus Biosciences, Inc.

  • 5Day Average: 1.22
  • 12Day Average: 1.24
  • 20Day Average: 1.24
  • 50Day Average: 1.5
  • 100Day Average: 1.33
  • 150Day Average: 1.16
  • 200Day Average: 1.11

CHRS Indicators & signals

Indicator MACD (12,26,9)

1.25, 1.32, -0.09
Indicator MACD is in negative zone

Indicator ADX (14)

0, 53.85, 53.85
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 49
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of CHRS Coherus Biosciences, Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
08 Mon Dec 2025 1.28 1.23 to 1.35 6.67% 1.94 times
05 Fri Dec 2025 1.20 1.18 to 1.27 -2.44% 1.11 times
04 Thu Dec 2025 1.23 1.20 to 1.25 0.82% 0.91 times
03 Wed Dec 2025 1.22 1.15 to 1.25 4.27% 1.08 times
02 Tue Dec 2025 1.17 1.16 to 1.32 -7.87% 0.91 times
01 Mon Dec 2025 1.27 1.26 to 1.33 -6.62% 0.88 times
28 Fri Nov 2025 1.36 1.33 to 1.39 3.82% 0.82 times
26 Wed Nov 2025 1.31 1.25 to 1.32 2.34% 1.06 times
25 Tue Nov 2025 1.28 1.24 to 1.31 0% 0.62 times
24 Mon Nov 2025 1.28 1.15 to 1.30 10.34% 1.64 times
21 Fri Nov 2025 1.16 1.09 to 1.17 5.45% 0.96 times
20 Thu Nov 2025 1.10 1.09 to 1.22 -5.17% 1.26 times

Videos related to: CHRS announcements Coherus Biosciences, Inc. announcements and dividends declared USA

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

CHRS announcements Coherus Biosciences, Inc. announcements and dividends declared USA

 

Back to top